KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) FCF Margin: 2018-2025

Historic FCF Margin for Moderna (MRNA) over the last 8 years, with Sep 2025 value amounting to -86.61%.

  • Moderna's FCF Margin rose 560.00% to -86.61% in Q3 2025 from the same period last year, while for Sep 2025 it was -118.86%, marking a year-over-year decrease of 3999.00%. This contributed to the annual value of -125.31% for FY2024, which is 6945.00% down from last year.
  • Per Moderna's latest filing, its FCF Margin stood at -86.61% for Q3 2025, which was up 86.66% from -649.30% recorded in Q2 2025.
  • In the past 5 years, Moderna's FCF Margin registered a high of 151.57% during Q1 2021, and its lowest value of -1,068.52% during Q1 2025.
  • Its 3-year average for FCF Margin is -353.52%, with a median of -95.03% in 2023.
  • Per our database at Business Quant, Moderna's FCF Margin surged by 156,407bps in 2021 and then crashed by 63,772bps in 2024.
  • Quarterly analysis of 5 years shows Moderna's FCF Margin stood at 44.24% in 2021, then slumped by 1,336bps to 30.88% in 2022, then tumbled by 1,658bps to 14.30% in 2023, then spiked by 1,707bps to 31.37% in 2024, then spiked by 560bps to -86.61% in 2025.
  • Its FCF Margin stands at -86.61% for Q3 2025, versus -649.30% for Q2 2025 and -1,068.52% for Q1 2025.